|
G |
A2m |
alpha-2-macroglobulin |
treatment |
IDA |
|
RGD |
PMID:1710603 |
RGD:10046021 |
NCBI chr 4:154,897,770...154,947,787
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
IEP |
|
RGD |
PMID:15878627 |
RGD:1559178 |
NCBI chr 6:40,872,936...40,920,700
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
ISO |
|
RGD |
PMID:9670863 |
RGD:2325244 |
NCBI chr 1:194,776,559...194,789,330
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
IEP |
protein:altered expression:spinal cord (rat) |
RGD |
PMID:19246105 |
RGD:2313022 |
NCBI chr20:3,651,435...3,657,341
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
|
IEP |
mRNA,protein:increased expression:spinal cord |
RGD |
PMID:20155814 |
RGD:14348972 |
NCBI chr 1:40,730,123...40,819,863
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
|
RGD |
PMID:15328042 |
RGD:5509618 |
NCBI chr10:55,559,060...55,567,535
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
severity |
ISO |
|
RGD |
PMID:28119027 |
RGD:14392778 |
NCBI chr 7:128,391,493...128,394,589
|
|
G |
Anxa1 |
annexin A1 |
|
IEP |
protein:increased expression:brain, astrocyte, macrophage |
RGD |
PMID:9472682 |
RGD:2306942 |
NCBI chr 1:227,287,713...227,306,739
|
|
G |
Apoe |
apolipoprotein E |
|
IEP |
|
RGD |
PMID:28578430 |
RGD:13703134 |
NCBI chr 1:88,481,889...88,485,816
|
|
G |
Aqp4 |
aquaporin 4 |
disease_progression severity |
ISO IEP |
|
RGD |
PMID:21056916 PMID:19660138 PMID:21157915 PMID:23707078 |
RGD:5148015, RGD:5490116, RGD:5490117, RGD:8696030 |
NCBI chr18:6,782,389...6,799,034
|
|
G |
B2m |
beta-2 microglobulin |
|
ISO |
|
RGD |
PMID:15837577 |
RGD:6482690 |
NCBI chr 3:129,549,236...129,555,354
|
|
G |
B4galt6 |
beta-1,4-galactosyltransferase 6 |
|
ISO |
mRNA:increased expression:astrocyte |
RGD |
PMID:25216636 |
RGD:14390079 |
NCBI chr18:11,958,382...12,015,247
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
IEP |
|
RGD |
PMID:23212569 |
RGD:10059360 |
NCBI chr 3:116,619,633...116,670,212
|
|
G |
C3 |
complement C3 |
|
IEP |
protein:increased expression:cerebrospinal fluid |
RGD |
PMID:22320401 |
RGD:7175513 |
NCBI chr 9:2,174,412...2,201,339
|
|
G |
C6 |
complement C6 |
severity |
IAGP |
|
RGD |
PMID:11970970 |
RGD:625607 |
NCBI chr 2:53,846,028...53,921,279
|
|
G |
Cacna1b |
calcium voltage-gated channel subunit alpha1 B |
|
IEP |
|
RGD |
PMID:11353727 |
RGD:1580151 |
NCBI chr 3:27,779,133...27,944,292
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
no_association |
ISO |
|
RGD |
PMID:19563774 |
RGD:5684360 |
NCBI chr 1:178,312,636...178,317,588
|
|
G |
Casp3 |
caspase 3 |
|
IEP |
protein:increased activity, increased expression:spinal cord |
RGD |
PMID:18521931 |
RGD:2311436 |
NCBI chr16:52,395,539...52,413,794
|
|
G |
Casp8 |
caspase 8 |
|
IEP |
protein:increased activity, increased expression:spinal cord |
RGD |
PMID:18521931 |
RGD:2311436 |
NCBI chr 9:67,747,109...67,806,699
|
|
G |
Casp9 |
caspase 9 |
|
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:18521931 |
RGD:2311436 |
|
|
G |
Cav3 |
caveolin 3 |
onset |
IEP |
Protein:increased expression:spinal cord, astrocyte |
RGD |
PMID:15925413 |
RGD:1582168 |
NCBI chr 4:147,137,993...147,153,967
|
|
G |
Cblb |
Cbl proto-oncogene B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20453840 |
|
NCBI chr11:62,058,829...62,225,904
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
|
IEP |
mRNA:decreased expression:lymph node |
RGD |
PMID:19865101 |
RGD:4145472 |
NCBI chr10:67,625,962...67,628,740
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
|
IEP |
mRNA:increased expression:lymph node |
RGD |
PMID:19865101 |
RGD:4145472 |
NCBI chr10:67,525,975...67,530,576
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP |
mRNA:increased expression:spinal cord mRNA:decreased expression:lymph node mRNA:increased expression:optic chiasma (rat) |
RGD |
PMID:17666800 PMID:19865101 PMID:11241588 |
RGD:2307114, RGD:4145472, RGD:8548888 |
NCBI chr10:67,503,077...67,504,875
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
|
IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:17666800 |
RGD:2307114 |
NCBI chr10:68,948,889...68,950,439
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO IEP |
protein:increased expression:brain (mouse) mRNA:increased expression:spinal cord |
RGD |
PMID:15833367 PMID:17666800 |
RGD:4890027, RGD:2307114 |
NCBI chr10:68,820,330...68,824,906
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
IEP IMP |
|
RGD |
PMID:14655765 PMID:14512166 |
RGD:5688165, RGD:5688167 |
NCBI chr 8:123,556,286...123,561,841
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:9655467 |
RGD:632391 |
NCBI chr 8:132,611,883...132,619,106
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:15034073 |
RGD:6893394 |
NCBI chr 8:123,586,100...123,634,178
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
IEP |
mRNA:increased expression:spinal cord, macrophage, microglia (rat) |
RGD |
PMID:17484785 |
RGD:4890436 |
NCBI chr 8:132,629,097...132,660,980
|
|
G |
Cd28 |
Cd28 molecule |
|
IMP |
|
RGD |
PMID:16061730 |
RGD:2307203 |
NCBI chr 9:69,660,316...69,689,192
|
|
G |
Cd4 |
Cd4 molecule |
treatment |
IEP IMP |
protein:decreased expression:T lymphocyte: |
RGD |
PMID:9138014 PMID:3097071 |
RGD:10058963, RGD:10058968 |
NCBI chr 4:159,355,147...159,381,636
|
|
G |
Cd80 |
Cd80 molecule |
|
IMP |
|
RGD |
PMID:9379015 |
RGD:6902906 |
NCBI chr11:75,760,073...75,798,978
|
|
G |
Cd86 |
CD86 molecule |
resistance disease_progression |
ISO IEP |
protein:increased expression:spinal cord, blood vessel (rat) |
RGD |
PMID:10477557 PMID:20451260 |
RGD:4892227, RGD:4892207 |
NCBI chr11:77,647,565...77,706,178
|
|
G |
Ciita |
class II, major histocompatibility complex, transactivator |
|
IAGP |
|
RGD |
PMID:15821736 |
RGD:1358146 |
NCBI chr10:5,139,947...5,187,493
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
IDA |
|
RGD |
PMID:21107918 PMID:10650887 PMID:7541143 |
RGD:6483335, RGD:6483351, RGD:6483353 |
NCBI chr10:86,011,504...86,018,063
|
|
G |
Comt |
catechol-O-methyltransferase |
treatment |
ISO |
|
RGD |
PMID:25242632 |
RGD:13450949 |
NCBI chr11:96,072,371...96,091,956
|
|
G |
Cpb2 |
carboxypeptidase B2 |
|
IEP |
|
RGD |
PMID:22768796 |
RGD:7243111 |
NCBI chr15:50,557,722...50,606,569
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
ISO IEP |
protein:increased expression:spinal cord |
RGD |
PMID:21679768 PMID:20162860 |
RGD:5686852, RGD:5686863 |
NCBI chr 8:57,264,962...57,300,010
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
ISO |
|
RGD |
PMID:9379015 |
RGD:6902906 |
NCBI chr 9:69,812,859...69,819,959
|
|
G |
Ctsc |
cathepsin C |
|
IEP |
|
RGD |
PMID:843913 |
RGD:1599653 |
NCBI chr 1:142,028,386...142,059,841
|
|
G |
Ctss |
cathepsin S |
|
ISO |
|
RGD |
PMID:21439785 |
RGD:5686915 |
NCBI chr 2:185,775,316...185,803,440
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
IEP |
|
RGD |
PMID:16053521 |
RGD:4891973 |
NCBI chr19:10,233,326...10,244,856
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
IEP IMP |
|
RGD |
PMID:16053521 PMID:24706865 |
RGD:4891973, RGD:9491767 |
NCBI chr 8:128,661,294...128,679,048
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:19616545 |
RGD:7257694 |
NCBI chr 9:75,729,493...75,735,868
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
IMP |
|
RGD |
PMID:21038468 |
RGD:5135506 |
NCBI chr X:66,844,318...66,846,969
|
|
G |
Dab2 |
DAB adaptor protein 2 |
disease_progression |
IEP |
|
RGD |
PMID:21890121 |
RGD:7243155 |
NCBI chr 2:57,241,947...57,294,893
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
|
ISO |
|
RGD |
PMID:24676147 |
RGD:150520045 |
NCBI chr 6:128,410,216...128,417,518
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
|
ISO |
|
RGD |
PMID:17947672 |
RGD:6482235 |
NCBI chr 1:64,985,161...64,993,274
|
|
G |
Dll4 |
delta like canonical Notch ligand 4 |
ameliorates |
ISO |
|
RGD |
PMID:21813770 |
RGD:155663662 |
NCBI chr 3:126,770,945...126,780,769
|
|
G |
Dusp10 |
dual specificity phosphatase 10 |
|
ISO |
|
RGD |
PMID:15306813 |
RGD:7775013 |
NCBI chr13:98,145,317...98,183,304
|
|
G |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
disease_progression |
IEP |
|
RGD |
PMID:19524108 |
RGD:9685491 |
NCBI chr 1:239,425,515...239,552,323
|
|
G |
Epo |
erythropoietin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18382691 |
|
NCBI chr12:19,204,258...19,207,948
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30661753 |
|
NCBI chr10:91,826,663...91,920,976
|
|
G |
Esr2 |
estrogen receptor 2 |
|
ISO |
|
RGD |
PMID:21565615 PMID:21182085 |
RGD:5508732, RGD:5508735 |
NCBI chr 6:100,589,553...100,645,240
|
|
G |
Faslg |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:10944459 |
RGD:12903984 |
NCBI chr13:76,680,885...76,706,042
|
|
G |
Fcgr2a |
Fc gamma receptor 2A |
|
ISO |
|
RGD |
PMID:12576552 |
RGD:5508383 |
NCBI chr13:85,813,516...85,830,269
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:8929896 PMID:9814819 |
RGD:8655647, RGD:9831448 |
NCBI chr 2:122,164,454...122,218,796
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
treatment |
ISO |
|
RGD |
PMID:18721816 |
RGD:10402153 |
NCBI chr12:12,333,050...12,504,750
|
|
G |
Foxo3 |
forkhead box O3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27742544 |
|
NCBI chr20:47,251,968...47,348,254
|
|
G |
Ghrh |
growth hormone releasing hormone |
resistance |
ISO |
|
RGD |
PMID:21846799 |
RGD:5687168 |
NCBI chr 3:145,992,762...146,012,528
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
treatment |
IDA |
|
RGD |
PMID:19620309 |
RGD:12905041 |
NCBI chr 4:146,865,712...146,869,621
|
|
G |
Gjc2 |
gap junction protein, gamma 2 |
|
ISO |
protein:decreased expression:white matter of spinal cord, gap junction (mouse) |
RGD |
PMID:22461072 |
RGD:13208593 |
NCBI chr10:43,962,642...43,971,358
|
|
G |
Gli1 |
GLI family zinc finger 1 |
|
ISO |
|
RGD |
PMID:18991353 |
RGD:12801440 |
NCBI chr 7:65,042,237...65,054,888
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
|
ISO |
mRNA, protein:decreased expression:spinal cord |
RGD |
PMID:9145307 |
RGD:6484657 |
NCBI chr16:9,640,312...9,673,961
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
IEP |
|
RGD |
PMID:22320401 |
RGD:7175513 |
NCBI chr10:39,529,335...39,537,406
|
|
G |
Havcr2 |
hepatitis A virus cellular receptor 2 |
|
ISO IEP |
mRNA:increased expression:spinal cord: |
RGD |
PMID:11823861 PMID:15913792 |
RGD:9686086, RGD:9686113 |
NCBI chr10:30,882,484...30,914,018
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO IMP |
|
RGD |
PMID:17085013 PMID:14691063 |
RGD:5508469, RGD:5508476 |
NCBI chr 2:29,732,163...29,754,276
|
|
G |
Ifnb1 |
interferon beta 1 |
ameliorates exacerbates treatment |
ISO IMP IDA |
|
RGD |
PMID:9578846 PMID:18997868 PMID:19380780 PMID:8955226 |
RGD:401854237, RGD:5147399, RGD:401854246, RGD:401854247 |
NCBI chr 5:108,066,650...108,067,487
|
|
G |
Ifng |
interferon gamma |
disease_progression treatment |
ISO |
|
RGD |
PMID:15661899 PMID:22896638 |
RGD:7987912, RGD:10755692 |
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Igf1 |
insulin-like growth factor 1 |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:7541143 |
RGD:6483353 |
NCBI chr 7:24,169,608...24,249,446
|
|
G |
Il10 |
interleukin 10 |
treatment |
IDA |
|
RGD |
PMID:23872438 |
RGD:7364993 |
NCBI chr13:45,024,921...45,029,586
|
|
G |
Il10ra |
interleukin 10 receptor subunit alpha |
|
IEP |
|
RGD |
PMID:12620647 |
RGD:2316323 |
NCBI chr 8:54,459,754...54,474,786
|
|
G |
Il12a |
interleukin 12A |
|
ISO |
|
RGD |
PMID:12471147 |
RGD:724447 |
NCBI chr 2:155,275,734...155,282,997
|
|
G |
Il12b |
interleukin 12B |
|
IEP |
mRNA, protein:increased expression:lymph node |
RGD |
PMID:19233473 |
RGD:4831840 |
NCBI chr10:29,390,300...29,405,194
|
|
G |
Il13 |
interleukin 13 |
severity |
ISO |
|
RGD |
PMID:18250480 PMID:7523520 |
RGD:5684366, RGD:5684367 |
NCBI chr10:38,290,926...38,293,483
|
|
G |
Il16 |
interleukin 16 |
|
IMP |
|
RGD |
PMID:17641011 |
RGD:5024940 |
NCBI chr 1:137,617,702...137,718,022
|
|
G |
Il17a |
interleukin 17A |
treatment |
IEP ISO IDA |
mRNA, protein:increased expression:lymph node |
RGD |
PMID:19233473 PMID:16785554 PMID:20003332 PMID:16200068 |
RGD:4831840, RGD:4889113, RGD:4888522, RGD:9212317 |
NCBI chr 9:30,640,844...30,644,331
|
|
G |
Il18 |
interleukin 18 |
|
IMP IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:9834127 PMID:9846824 |
RGD:4889543, RGD:4889542 |
NCBI chr 8:59,802,072...59,829,275
|
|
G |
Il18r1 |
interleukin 18 receptor 1 |
|
IEP |
mRNA:increased expression:lymph node |
RGD |
PMID:19269041 |
RGD:2311529 |
NCBI chr 9:42,727,416...42,760,971
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:7593560 |
RGD:8551836 |
NCBI chr 3:27,509,836...27,525,738
|
|
G |
Il21 |
interleukin 21 |
|
IDA |
|
RGD |
PMID:18997868 |
RGD:5147399 |
NCBI chr 2:120,117,105...120,127,012
|
|
G |
Il21r |
interleukin 21 receptor |
no_association disease_progression |
ISO |
|
RGD |
PMID:18546146 PMID:18353312 |
RGD:6892939, RGD:6892940 |
NCBI chr 1:180,168,028...180,195,690
|
|
G |
Il22 |
interleukin 22 |
|
IEP |
|
RGD |
PMID:19269041 |
RGD:2311529 |
NCBI chr 7:53,801,206...53,805,673
|
|
G |
Il27 |
interleukin 27 |
|
ISO |
protein:decreased expression:blood serum (mouse) |
RGD |
PMID:33403844 |
RGD:126790527 |
NCBI chr 1:181,173,108...181,178,720
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
|
IEP |
|
RGD |
PMID:19269041 |
RGD:2311529 |
NCBI chr17:66,849,974...66,898,665
|
|
G |
Il4 |
interleukin 4 |
treatment |
ISO IEP |
|
RGD |
PMID:18239607 PMID:1383385 |
RGD:7829778, RGD:8142395 |
NCBI chr10:38,272,003...38,277,549
|
|
G |
Il6 |
interleukin 6 |
|
IEP ISO |
protein:increased expression:oligodendrocytes (rat) |
RGD |
PMID:9358769 PMID:23322593 |
RGD:2307412, RGD:12791289 |
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Itga4 |
integrin subunit alpha 4 |
treatment susceptibility |
IMP IDA |
rat bone marrow cells in a mouse model |
RGD |
PMID:12626659 PMID:18722022 |
RGD:9698418, RGD:9698436 |
NCBI chr 3:84,569,487...84,646,276
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
|
ISO |
|
RGD |
PMID:17947672 |
RGD:6482235 |
NCBI chr 3:124,406,783...124,442,220
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
|
RGD |
PMID:22066025 |
RGD:6483041 |
NCBI chr 1:236,408,905...236,468,769
|
|
G |
Jak3 |
Janus kinase 3 |
treatment |
IDA |
|
RGD |
PMID:25012120 |
RGD:11533939 |
NCBI chr16:18,418,807...18,432,515
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
|
RGD |
PMID:19233483 |
RGD:5684404 |
NCBI chr14:32,572,031...32,615,204
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
|
ISO |
|
RGD |
PMID:25972476 |
RGD:12910744 |
NCBI chr14:32,901,615...32,978,895
|
|
G |
Lrp1 |
LDL receptor related protein 1 |
|
ISO |
protein:increased expression:cerebellum, spinal cord |
RGD |
PMID:19299462 |
RGD:13800552 |
NCBI chr 7:65,265,639...65,346,196
|
|
G |
Lta |
lymphotoxin alpha |
|
IEP |
mRNA:increased expression:spinal cord mRNA:increased expression:brain |
RGD |
PMID:7593556 PMID:9184655 |
RGD:1625038, RGD:4143220 |
NCBI chr20:3,622,291...3,625,852
|
|
G |
Mapt |
microtubule-associated protein tau |
treatment |
IDA |
|
RGD |
PMID:15494405 |
RGD:1358431 |
NCBI chr10:89,638,618...89,736,108
|
|
G |
Mbp |
myelin basic protein |
|
ISO |
human sequence peptide in a rat model; associated with Herpesviridae infections CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11501064 PMID:15159442 PMID:17884951 PMID:24070732 PMID:16285900 PMID:12811845 More...
|
RGD:7349334, RGD:30296670 |
NCBI chr18:75,855,878...75,966,404
|
|
G |
Mdk |
midkine |
|
IEP |
|
RGD |
PMID:9814819 |
RGD:9831448 |
NCBI chr 3:77,901,134...77,903,997
|
|
G |
Mir146a |
microRNA 146a |
|
ISO |
mRNA:increased expression:spinal cord (mouse) |
RGD |
PMID:22660635 |
RGD:155663483 |
NCBI chr10:28,349,996...28,350,090
|
|
G |
Mir23b |
microRNA 23b |
treatment |
ISO |
mRNA:decreased expression:spinal cord (mouse) |
RGD |
PMID:22660635 PMID:22660635 |
RGD:155663483, RGD:155663483 |
NCBI chr17:1,813,667...1,813,763
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
IDA |
|
RGD |
PMID:19922364 |
RGD:2325703 |
NCBI chr19:30,327,643...30,355,856
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
|
IEP |
|
RGD |
PMID:9549496 |
RGD:8547909 |
NCBI chr 8:13,133,043...13,140,761
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
IEP ISO |
protein:increased expression:multiple tissues |
RGD |
PMID:9549496 PMID:24797785 PMID:20810258 PMID:22800566 |
RGD:8547909, RGD:13204801, RGD:13204762, RGD:8547936 |
NCBI chr 3:174,103,474...174,111,434
|
|
G |
Mobp |
myelin-associated oligodendrocyte basic protein |
|
ISO |
|
RGD |
PMID:10623862 |
RGD:27226694 |
NCBI chr 8:119,869,504...119,899,605
|
|
G |
Mog |
myelin oligodendrocyte glycoprotein |
|
IDA ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12904460 PMID:16931536 PMID:17654737 PMID:17728465 PMID:18566399 PMID:18667803 PMID:21068375 PMID:21317386 PMID:21341682 PMID:23360710 PMID:23547115 PMID:23639249 PMID:30661753 PMID:10384097 PMID:14624757 PMID:14624757 PMID:12799014 More...
|
RGD:9685372, RGD:9685375, RGD:9685375, RGD:9685373 |
NCBI chr20:1,514,110...1,528,716
|
|
G |
Mt1 |
metallothionein 1 |
|
ISO |
mRNA:increased expression:brain (mouse) |
RGD |
PMID:19619133 |
RGD:6484112 |
NCBI chr19:10,831,959...10,832,975
|
|
G |
Mt2A |
metallothionein 2A |
|
ISO |
mRNA:increased expression:brain (mouse) |
RGD |
PMID:19619133 |
RGD:6484112 |
NCBI chr19:10,837,934...10,838,708
|
|
G |
Mt3 |
metallothionein 3 |
|
ISO |
mRNA:increased expression:brain (mouse) |
RGD |
PMID:19619133 |
RGD:6484112 |
NCBI chr19:10,848,754...10,850,158
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
|
IEP |
protein:decreased expression:hippocampus |
RGD |
PMID:17064783 |
RGD:40924670 |
NCBI chr 8:58,762,088...59,062,131
|
|
G |
Nefl |
neurofilament light chain |
|
IEP |
protein:increased expression:cerebrospinal fluid, spinal cord |
RGD |
PMID:16182933 |
RGD:2299007 |
NCBI chr15:46,477,330...46,481,203
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19910389 |
|
NCBI chr 3:81,001,529...81,031,165
|
|
G |
Ngf |
nerve growth factor |
|
IEP |
protein, mRNA:increased expression:thalamus and cortex, CNS |
RGD |
PMID:8866783 |
RGD:5508386 |
NCBI chr 2:192,589,580...192,642,971
|
|
G |
Ngfr |
nerve growth factor receptor |
severity |
ISO IEP |
mRNA:increased expression:central nervous system |
RGD |
PMID:16519950 PMID:8866783 |
RGD:5508312, RGD:5508386 |
NCBI chr10:81,012,077...81,030,305
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
|
RGD |
PMID:21857957 |
RGD:5509069 |
NCBI chr10:64,313,335...64,349,221
|
|
G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
|
ISO |
|
RGD |
PMID:21266776 |
RGD:6480877 |
NCBI chr 1:95,041,967...95,047,358
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
ISO |
|
RGD |
PMID:17322387 |
RGD:4892331 |
NCBI chr18:31,522,783...31,644,508
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
|
IEP |
mRNA:increased expression:brain subventricular zone: |
RGD |
PMID:15589512 |
RGD:5684777 |
NCBI chr 2:175,534,844...175,551,664
|
|
G |
Olig1 |
oligodendrocyte transcription factor 1 |
treatment |
ISO |
|
RGD |
PMID:24941845 |
RGD:40902822 |
NCBI chr11:30,514,379...30,516,521
|
|
G |
Olig2 |
oligodendrocyte transcription factor 2 |
treatment |
ISO IEP |
|
RGD |
PMID:24941845 PMID:29682587 |
RGD:40902822, RGD:40902863 |
NCBI chr11:30,475,510...30,478,886
|
|
G |
Pdcd1 |
programmed cell death 1 |
susceptibility |
ISO |
|
RGD |
PMID:24648472 |
RGD:40818258 |
NCBI chr 9:101,866,124...101,879,278
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
treatment |
IDA |
|
RGD |
PMID:16042218 |
RGD:11080975 |
NCBI chr 7:113,419,882...113,438,343
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
treatment |
IDA |
|
RGD |
PMID:16042218 |
RGD:11080975 |
NCBI chr14:33,360,027...33,408,604
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
treatment |
IDA |
|
RGD |
PMID:16042218 |
RGD:11080975 |
NCBI chr18:56,770,348...56,809,228
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
ISO |
|
RGD |
PMID:20303183 |
RGD:6482686 |
NCBI chr 6:54,494,247...54,529,563
|
|
G |
Plp1 |
proteolipid protein 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21068375 PMID:24941845 |
RGD:40902822 |
NCBI chr X:104,933,921...104,993,317
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17261635 |
|
NCBI chr 7:118,712,261...118,780,723
|
|
G |
Prf1 |
perforin 1 |
|
ISO |
|
RGD |
PMID:20708278 |
RGD:6482806 |
NCBI chr20:29,246,202...29,251,712
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
severity |
ISO |
|
RGD |
PMID:19486896 |
RGD:6484540 |
NCBI chr 2:55,967,766...56,003,450
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO IEP |
protein:increased expression:cerebral cortex, cerebellum, spinal cord protein:increased expression:microglia, macrophage, |
RGD |
PMID:21667309 PMID:10229132 |
RGD:5688149, RGD:5688250 |
NCBI chr 3:39,981,419...40,002,993
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO IEP |
protein:increased expression:cerebral cortex, cerebellum, spinal cord protein:increased expression:endothelial cell |
RGD |
PMID:21667309 PMID:10229132 |
RGD:5688149, RGD:5688250 |
NCBI chr13:64,714,063...64,722,320
|
|
G |
Ptn |
pleiotrophin |
|
IEP |
mRNA:increased expression:spinal cord (rat) |
RGD |
PMID:9814819 |
RGD:9831448 |
NCBI chr 4:66,260,764...66,342,614
|
|
G |
Qki |
QKI, KH domain containing RNA binding |
|
IEP |
|
RGD |
PMID:22740327 |
RGD:10045997 |
NCBI chr 1:50,387,716...50,501,568
|
|
G |
Rangrf |
RAN guanine nucleotide release factor |
|
IDA |
|
RGD |
PMID:8557821 |
RGD:6771380 |
NCBI chr10:53,677,467...53,678,880
|
|
G |
Rhoa |
ras homolog family member A |
severity |
IEP |
protein:increased expression:microglial cell, brain |
RGD |
PMID:17983427 |
RGD:2298887 |
NCBI chr 8:117,870,548...117,904,303
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
|
IMP IDA |
|
RGD |
PMID:18050272 PMID:9834080 PMID:16723470 |
RGD:5147622, RGD:5147666, RGD:5147639 |
NCBI chr20:4,575,134...4,579,727
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
|
IMP IDA ISO |
|
RGD |
PMID:16723470 PMID:9834080 PMID:16194572 |
RGD:5147639, RGD:5147666, RGD:5147647 |
NCBI chr20:4,598,475...4,604,118
|
|
G |
RT1-Da |
RT1 class II, locus Da |
|
ISO |
|
RGD |
PMID:8676084 |
RGD:5490166 |
NCBI chr20:4,513,464...4,518,457
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
ISO |
|
RGD |
PMID:16194572 |
RGD:5147647 |
NCBI chr20:4,548,664...4,558,237
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
mRNA,protein:increased expression,increased activity:spinal cord, astrocyte: |
RGD |
PMID:11733372 |
RGD:13208549 |
NCBI chr12:25,237,977...25,248,356
|
|
G |
Shh |
sonic hedgehog signaling molecule |
|
IEP ISO |
|
RGD |
PMID:15892298 PMID:18991353 |
RGD:12801423, RGD:12801440 |
NCBI chr 4:6,954,017...6,963,170
|
|
G |
Sigmar1 |
sigma non-opioid intracellular receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30661753 |
|
NCBI chr 5:56,904,155...56,907,012
|
|
G |
Sirt1 |
sirtuin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23547115 |
|
NCBI chr20:25,305,953...25,328,000
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
treatment |
IDA |
|
RGD |
PMID:22436018 |
RGD:9999395 |
NCBI chr 3:173,501,573...173,503,822
|
|
G |
Sncb |
synuclein, beta |
|
IDA |
|
RGD |
PMID:12496452 |
RGD:730073 |
NCBI chr17:9,846,802...9,855,013
|
|
G |
Srsf9 |
serine and arginine rich splicing factor 9 |
treatment |
ISO |
|
RGD |
PMID:20616573 |
RGD:11040805 |
NCBI chr12:41,278,225...41,284,502
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
ISO |
|
RGD |
PMID:22066025 |
RGD:6483041 |
NCBI chr 9:56,911,522...56,951,926
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
|
RGD |
PMID:22066025 PMID:17878325 |
RGD:6483041, RGD:6892946 |
NCBI chr10:86,311,528...86,363,513
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
|
IEP |
|
RGD |
PMID:11240014 |
RGD:7207888 |
NCBI chr 9:49,472,660...49,588,540
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
IEP |
mRNA, protein:increased expression:central nervous system |
RGD |
PMID:17204936 |
RGD:2302088 |
NCBI chr 1:90,324,312...90,340,627
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
|
IEP |
mRNA, protein:decreased expression:central nervous system |
RGD |
PMID:17204936 |
RGD:2302088 |
NCBI chr13:98,160,075...98,261,771
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:15878627 |
RGD:1559178 |
NCBI chr 7:19,408,539...19,459,558
|
|
G |
Tlr2 |
toll-like receptor 2 |
treatment |
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:18644848 PMID:33358978 |
RGD:2312575, RGD:597538508 |
NCBI chr 2:171,499,189...171,504,831
|
|
G |
Tlr4 |
toll-like receptor 4 |
treatment |
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:18644848 PMID:33358978 |
RGD:2312575, RGD:597538508 |
NCBI chr 5:85,161,247...85,174,882
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
IEP |
|
RGD |
PMID:11421579 |
RGD:12904661 |
NCBI chr20:3,626,685...3,629,303
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
IDA |
|
RGD |
PMID:12196270 |
RGD:1580348 |
NCBI chr 2:206,723,050...206,742,783
|
|
G |
Vdr |
vitamin D receptor |
treatment |
ISO |
|
RGD |
PMID:21318047 PMID:21287548 |
RGD:8158064, RGD:13210791 |
NCBI chr 7:130,864,764...130,916,757
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
IDA ISO IEP |
mRNA:decreased expression:Cerebrospinal Fluid: mRNA,protein:decreased expression:spinal cord: |
RGD |
PMID:12387457 PMID:17083617 PMID:17083617 |
RGD:634258, RGD:7421596, RGD:7421596 |
NCBI chr 9:22,452,854...22,468,194
|
|
G |
Vip |
vasoactive intestinal peptide |
|
ISO |
|
RGD |
PMID:20978211 |
RGD:5685386 |
NCBI chr 1:44,470,232...44,478,561
|
|
G |
Xbp1 |
X-box binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30661753 |
|
NCBI chr14:84,604,623...84,609,707
|
|
|
G |
Mag |
myelin-associated glycoprotein |
|
IEP |
protein:decreased expression:optic nerve |
RGD |
PMID:9820787 |
RGD:9685300 |
NCBI chr 1:86,148,227...86,163,726
|
|
G |
Zc3h12a |
zinc finger CCCH type containing 12A |
disease_progression |
ISO |
|
RGD |
PMID:26320658 |
RGD:11534569 |
NCBI chr 5:142,661,193...142,670,051
|
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP |
mRNA:increased expression:spinal cord (rat) |
RGD |
PMID:12098510 |
RGD:8655962 |
NCBI chr10:67,503,077...67,504,875
|
|
G |
Nefh |
neurofilament heavy chain |
|
ISO |
protein:decreased expression:spinal cord: |
RGD |
PMID:12742652 |
RGD:27226817 |
NCBI chr14:84,044,428...84,054,413
|
|
G |
Plp1 |
proteolipid protein 1 |
|
ISO |
human sequence peptide in a mouse model; associated with Herpesviridae infections |
RGD |
PMID:12811845 |
RGD:30296670 |
NCBI chr X:104,933,921...104,993,317
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
|
RGD |
PMID:17983428 |
RGD:13208507 |
NCBI chr12:25,237,977...25,248,356
|
|